A carregar...
Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance
The use of direct-acting antivirals (DAAs) to treat chronic hepatitis C has resulted in a significant increase in rates of sustained viral response (around 90%-95%) as compared with the standard treatment of peginterferon/ribavirin. Despite this, however, the rates of therapeutic failure in daily cl...
Na minha lista:
| Publicado no: | World J Gastroenterol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4970473/ https://ncbi.nlm.nih.gov/pubmed/27547001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i29.6573 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|